Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RASONQUE safely and effectively. See full prescribing information for RASONQUE. RASONQUE™ (daraxonrasib) tablets, for oral useInitial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy.
- generic_name
- daraxonrasib
- product_names
- daraxonrasib
- ndc
- 85219-101, 85219-101-01, 85219-104, 85219-104-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en